This week our biotech pick Theravance Biopharma (Nasdaq: TBPH) announced the results of its 12-month long Phase 3 study of revefenacin (TD-4208), jointly conducted with Mylan (Nasdaq: MYL). As we discussed in the June 9 weekly issue, the results released earlier this year from the first two Phase 3 studies… Read More
Analyst Articles
In a short span of time, Steve Easterbrook has rejuvenated a struggling restaurant chain and an underperforming stock. We take a look at the multi-pronged approach that has turned a market laggard into one of the better performing stocks of 2017. Read More
AAR Corp (NYSE: AIR) has enjoyed a solid week (up about 6 percent from last week’s closing price) thanks to and a general rally in airline shares. Since joining our portfolio on February 24, 2017, AIR has returned better than 10 percent, which compares favorably to the S&P 500’s 4.5… Read More
1) Sell to close the SPDR S&P 500 ETF (SPY) October 20, 2017 $241 put. 2) Sell to close the Energy Select Sector SPDR Fund (XLE) December 15, 2017 $65 put. We recommend closing out both put options at this time. … Read More
When it comes to companies struck by bad PR incidents, investors should carefully evaluate industry dynamics and customer behaviors to determine whether the bad publicity will have any lasting effect on a company's top and bottom lines. Read More
The U.S. Labor Department today reported that in June the economy added 222,000 non-farm jobs, well above the 178,000 expected by economists. This is the best monthly showing since February and brings the first-half average to 180,000, about in line with the 2016 monthly average of 187,000. The unemployment rate… Read More
A look at Buffalo Wild Wings a month after Marcato won the proxy fight. Can an activist investor restore B-Dubs' past glory? Read More
Water irrigation company Lindsay Corporation (NYSE: LNN) reported earnings for its fiscal third quarter (ended May 31) yesterday. Net earnings for the quarter were $11 million, or $1.02 per share, a 14 percent year-over-year improvement. Irrigation revenues in both the U.S. and international markets modestly improved, while revenues from the… Read More
Our indicators have done quite well for us. Since the beginning of 2016, when we began to lean heavily on our proprietary indicators, 22 out of 28 indicator-based ETF option trades have been profitable (gross return, not counting commission). Of the 6 that were not profitable, one was exactly break… Read More
A look at the Number-2 company in a lucratively growing online market, the largest in the world. Read More